CBLL1 and colorectal cancer: In this study, by using robust bioinformatics and machine learning methods, we provide evidence that high CBLL1 mRNA expression is specifically associated with consensus molecular subtype 2 (CMS2) in colorectal cancer patients, which is characterised by strong activation of the WNT and MYC pathways.